MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.
SNPHY
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Santen Pharmaceutical (SNPHY) Ownership - Who owns Santen Pharmaceutical?

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
Grand Front Osaka Tower A
Phone
+81 663217000
Employees
4073
Web
http://www.santen.co.jp

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
3.26B
P/E Ratio
15.60
Total Cash
62.32B
Projected Growth
N/A
Total Debt
40.09B
Revenue
270.24B
Risk (Beta)
0.37
Dividend Yield
0.03
Total Cash/Share
168.46
Total Debt/Equity
N/A
Revenue/Share
5.12 USD as % of share price

Fundamentals

SNPHY
Capitalization
3.26B
P/E Ratio
15.60
Risk (Beta)
0.37
Dividend Yield
0.03
Total Cash
62.3B
Total Cash/Share
168.46
Total Debt
40.1B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.12%
Revenue
270B
ROE
N/A
Book Value
301B
P/B Ratio
1.53
Cash Flow
N/A
Earnings
-21.45
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.68B
Current Ratio
2.73
Current Revenue Per Employee
16424334.00
Dividends Per Share - Security
0.00
EBITDA
17.2B
Float
N/A
Float - Current
N/A
Gross Income Margin
58.31
Revenue To Assets
-1.93
Shares Held By Institutions
631K
Shares Outstanding - Current
370M
Total Liabilities
120B
Total Volume MTD
N/A
Value
-1
Gain YTD
10.436
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
Grand Front Osaka Tower A
Phone
+81 663217000
Employees
4073
Web
http://www.santen.co.jp